Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
Stay updated with breaking news from Glenn Whaley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Jessica Breu: Good morning, and welcome to Immunic's First Quarter 2023 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
Jessica Breu: Good morning and welcome to Immunic's Fourth Quarter and Year End 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q2 2022 Earnings Conference Call August 4, 2022 08:00 ET Company Participants Jessica Breu - Head, Investor Relations and Communications Daniel Vitt -...